E-ISSN: 1305-9327 ISSN: 1305-9319
The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma
PDF
Cite
Share
Request
Researches
VOLUME: 12 ISSUE: 1
P: 24-32
March 2016

The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma

Med J Bakirkoy 2016;12(1):24-32
DOI: 10.5350/BTDMJB201612105
Senem Karabulut 1
Mehmet Karabulut 2
Halil Alış 2
Nergiz Dağoğlu 3
Makbule Tambaş 3
Selin Kapan 2
Ebru Oran 2
Hilal Oğuz 4
Faruk Taş 1
1. İstanbul Üniversitesi, Onkoloji Enstitüsü, Tıbbi Onkoloji Bilim Dalı, İstanbul
2. Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, İstanbul
3. İstanbul Üniversitesi, Onkoloji Enstitüsü, Radyasyon Onkolojisi Anabilim Dalı, İstanbul
4. İstanbul Üniversitesi, Onkoloji Enstitüsü, İstanbul Üniversitesi, Onkoloji Enstitüsü, Temel Onkoloji Bilim Dalı, İstanbul
No information available.
No information available
Received Date: 28.05.2015
Accepted Date: 11.09.2015
PDF
Cite
Share
Request

ABSTRACT

Objective:

Fibronectin (FN),vitronectin (VTN), and tip IV kollagen (Kol IV) are the important components of the extracellular matrix (ECM) proteins. The objective of this study was to determine the clinical significance of serum levels of these molecules in pancreas adenocarcinoma (PA) patients.

Material and Methods:

A total of 33 patients with a pathologically confirmed diagnosis of PA and age- and sex-matched 30 healthy controls were enrolled into this study. Serum FN, VTN, and Kol IV concentrations were determined by the enzyme-linked immuno-sorbent assay (ELISA) method.

Results:

The median age at diagnosis was 59 years, range 32 to 84 years where 61% of the patients were male. Majority of the patients (70%) had good performance status (0-1). The most common tumor localization was head of pancreas (68%). Of the 9 patients who undergone surgical intervention, 5 patients (15%) had pancreaticoduodenectomy, while palliative surgery was performed in the remaining 4 (12%) patients. The baseline serum FN, VTN, and Kol IV levels were significantly higher in patients with PA than in the healthy control group (p=0.001, p=0.007 and p<0.001, respectively). Additionally, serum FN levels of the patients with jaundice (p=0.02), serum VTN levels of older patients - (p=0.03), and serum Kol IV levels of older patients, patients with metastasis and liver metastasis presence were detected to be significantly higher compared with others (p=0.009, p=0.05 and p=0.04, respectively). However, serum FN, VTN, and Kol IV levels had no prognostic role for outcome in PA patients (p=0.45, p=0.69 and p=0.11, respectively).

Conclusions:

Serum levels of ECM proteins were diagnostic markers in PA patients. However, their predictive and prognostic values were not determined.

Keywords:
Pancreas adenocarcinoma, fibronectin, vitronectin, Tip IV kollagen, diagnosis